Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 6,003 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 8,866 shares (to pay taxes)
  3. 4 Planned sale VP, Finance (Interim PAO) sold 1,327 shares at $35.69 ($47,361)
  4. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 1,869 shares (to pay taxes)
  5. 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 2,822 shares (to pay taxes)
  6. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 1,869 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 3,950 shares (to pay taxes)
  8. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 3,950 shares (to pay taxes)
  9. 4 Derivatives Options or other derivatives
  10. 4 Planned sale EVP R&D, Chief Medical Officer sold 349,340 shares at an average $33.92 ($11,848,975)
  11. 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 79,925 shares (to pay taxes)
  12. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 7,399 shares (to pay taxes)
  13. 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 10,647 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 15,083 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 9,752 shares (to pay taxes)
  16. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 7,514 shares (to pay taxes)
  17. 4 Planned sale EVP R&D, Chief Medical Officer sold 100,918 shares at $32.05 ($3,234,382)
  18. 4 Planned sale EVP R&D, Chief Medical Officer sold 61,151 shares at $32.07 ($1,961,406)
  19. 4 Planned sale Director sold 2,691 shares at $31.85 ($85,708)
  20. 4 Planned sale EVP R&D, Chief Medical Officer sold 9,221 shares at $31.50 ($290,462)

Page 6 of 67 · 1,323 filings